BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37762974)

  • 1. Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases.
    Cui Y; Wang Y; Wang S; Du B; Li X; Li Y
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.
    Li M; Younis MH; Zhang Y; Cai W; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2844-2868. PubMed ID: 35098327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
    Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
    Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
    Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
    J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of [
    Zhou Y; Yang X; Liu H; Luo W; Liu H; Lv T; Wang J; Qin J; Ou S; Chen Y
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3493-3501. PubMed ID: 33829416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases.
    Yang P; Luo Q; Wang X; Fang Q; Fu Z; Li J; Lai Y; Chen X; Xu X; Peng X; Hu K; Nie X; Liu S; Zhang J; Li J; Shen C; Gu Y; Liu J; Chen J; Zhong N; Su J
    Am J Respir Crit Care Med; 2023 Jan; 207(2):160-172. PubMed ID: 35984444
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of pulmonary fibrosis induced by paraquat using Al
    Song CY; Liu ZF; Wang P; Su XH; Lu YQ
    Intern Emerg Med; 2023 Sep; 18(6):1673-1679. PubMed ID: 37284931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool.
    Sharma P; Singh SS; Gayana S
    Clin Nucl Med; 2021 Mar; 46(3):e141-e150. PubMed ID: 33351507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
    Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
    J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
    EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review.
    Zhao L; Chen J; Pang Y; Fu K; Shang Q; Wu H; Sun L; Lin Q; Chen H
    Theranostics; 2022; 12(4):1557-1569. PubMed ID: 35198057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
    Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
    Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
    Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
    Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.
    Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.
    Schmidkonz C; Rauber S; Atzinger A; Agarwal R; Götz TI; Soare A; Cordes M; Prante O; Bergmann C; Kleyer A; Ritt P; Maschauer S; Hennig P; Toms J; Köhner M; Manger B; Stone JH; Haberkorn U; Baeuerle T; Distler JHW; Agaimy A; Kuwert T; Schett G; Ramming A
    Ann Rheum Dis; 2020 Nov; 79(11):1485-1491. PubMed ID: 32719042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
    Roustaei H; Kiamanesh Z; Askari E; Sadeghi R; Aryana K; Treglia G
    Contrast Media Mol Imaging; 2022; 2022():3948873. PubMed ID: 35280710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting Fibroblast Activation Proteins in Lymphoma Using
    Jin X; Wei M; Wang S; Wang G; Lai Y; Shi Y; Zhang Y; Yang Z; Wang X
    J Nucl Med; 2022 Feb; 63(2):212-217. PubMed ID: 34049984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.